[Protection for the ischemic myocardium: a transition between the experimental laboratory and medical practice].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D002118:Calcium / Q000037:antagonists & inhibitors; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007423:Intra-Aortic Balloon Pumping; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery; D009204:Myocardial Revascularization; D010477:Perfusion; D011188:Potassium / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000319:Adrenergic beta-Antagonists; D007328:Insulin; D014665:Vasodilator Agents; D006821:Hyaluronoglucosaminidase; D011188:Potassium; D002118:Calcium
Proteção ao miocárdio isquêmico: a transição entre o laboratório experimental e a prática mêdica.